You are here

A Study To Evaluate PF-06730512 In Adults With Primary Focal Segmental Glomerulosclerosis

Last updated on August 2, 2019

FOR MORE INFORMATION
Study Location
Ronald Reagan UCLA Medical Center
Los Angeles, California, 90095 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Focal Segmental Glomerulosclerosis (FSGS)
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

1. Adults age 18 years and older who has a confirmed diagnosis of primary FSGS.

2. Estimated glomerular filtration rate (eGFR) greater than or equal to 45 ml/min/1.73
m2. If eGFR is 30 - 45 ml/min/1.73 m2, a recent biopsy (within 12 months prior to
Screening) must demonstrate

3. Urine protein:creatinine ratio (UPCR) greater than 1.5 g/g at screening.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

1. Diagnosis of secondary and/or collapsing FSGS.

2. Advanced chronic changes on renal biopsy as evidenced by greater than 50%
tubulointerstitial fibrosis.

3. Body mass index (BMI) greater than 40 kg/m2.

NCT03448692
Pfizer
Recruiting
A Study To Evaluate PF-06730512 In Adults With Primary Focal Segmental Glomerulosclerosis

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now